Operating Expenses Summary of Lexston Life Sciences Corp.

Lexston Life Sciences Corp.'s latest annual operating expenses in 2023 was 674.71 Thousand CAD , down -22.58% from previous year.
Lexston Life Sciences Corp.'s latest quarterly operating expenses in 2024 Q1 was 479.68 Thousand CAD , up 261.17% from previous quarter.
Lexston Life Sciences Corp. reported a annual operating expenses of 871.53 Thousand CAD in annual operating expenses 2022, down -58.6% from previous year.
Lexston Life Sciences Corp. reported a annual operating expenses of 2.1 Million CAD in annual operating expenses 2021, up 281.93% from previous year.
Lexston Life Sciences Corp. reported a quarterly operating expenses of 366.1 Thousand CAD for 2023 Q3, up 178.19% from previous quarter.
Lexston Life Sciences Corp. reported a quarterly operating expenses of 131.6 Thousand CAD for 2023 Q2, up 24.39% from previous quarter.

Annual Operating Expenses Chart of Lexston Life Sciences Corp. (2023 - 2019)

Name	Operating Expenses	Operating Expenses Difference
Algernon Pharmaceuticals Inc.	5.19 Million CAD	87.004%
Asep Medical Holdings Inc	7.74 Million CAD	91.285%
BetterLife Pharma Inc.	3.24 Million CAD	79.177%
BioVaxys Technology Corp.	2.4 Million CAD	71.917%
ChitogenX Inc.	2.83 Million CAD	76.158%
Rapid Dose Therapeutics Corp.	4.2 Million CAD	83.968%
Defence Therapeutics Inc.	12.65 Million CAD	94.669%
Entheon Biomedical Corp.	564.31 Thousand CAD	-19.564%
Gemina Laboratories Ltd.	5.08 Million CAD	86.734%
Glow Lifetech Corp.	25.71 Thousand CAD	-2523.83%
Pharmala Biotech Holdings Inc.	1.21 Million CAD	44.561%
Doseology Sciences Inc.	72.08 Thousand CAD	-835.977%
MYND Life Sciences Inc.	1.47 Million CAD	54.25%
Nova Mentis Life Science Corp.	1.2 Million CAD	43.881%
PharmaTher Holdings Ltd.	3.04 Million CAD	77.835%
PreveCeutical Medical Inc.	963.12 Thousand CAD	29.945%
Telescope Innovations Corp.	6.35 Million CAD	89.378%